Corrections Required for Tables 1 and 2
Overview
This report addresses corrections needed in the tables of a clinical trial on transcutaneous electrical nerve stimulation (TENS) for fibromyalgia, specifically detailing the errors in the labeling of scales in Tables 1 and 2.
Background
Accurate data representation in clinical trials is crucial for the interpretation of results and subsequent clinical applications. The study of TENS in fibromyalgia is particularly relevant as it explores nonpharmacologic interventions for managing pain, which is a significant concern for patients. Ensuring the integrity of published data supports evidence-based practice in fibromyalgia treatment.
Data Highlights
No numerical data or trial data is presented in the source material.
Key Findings
The Rapid Assessment of Physical Activity (RAPA) 2 scale for strength and flexibility should be listed as 0 to 3 in Table 1. Table 2 incorrectly labeled the second listing of 'Fibromyalgia impact (FIQR, scale of 0-100)' which should be 'Strength and flexibility (RAPA 2, scale of 0-3)'. These corrections are essential for accurate interpretation of clinical trial results.Clinical Implications
Healthcare professionals should be aware of the importance of accurate data representation in clinical trials, particularly when considering nonpharmacologic treatments for fibromyalgia. Corrections in published articles should be closely monitored to ensure that clinical decisions are based on reliable information.
Conclusion
The corrections made to Tables 1 and 2 are critical for the accurate interpretation of the trial's findings on TENS in fibromyalgia, ensuring data accuracy is essential for advancing clinical practice and improving patient outcomes.
Related Resources & Content
- Erratum: 3D Reconstruction from Microscopic Imaging for Computer-Assisted Eye Surgery, International Journal of Computer Assisted Radiology and Surgery, 2024 -- Correction to figures
- Erratum: Outcomes of Isokinetic and Functional Shoulder Assessment Following Arthroscopic Capsulolabral Stabilization, Archives of Orthopaedic and Trauma Surgery, 2022 -- Correction to Table 2
- Amendment to: Pediatric Central Nervous System Tumors in Patients Aged Under 5: Insights on Treatment Challenges, Survival Rates, and Long-Term Outcomes, Journal of Neuro-Oncology, 2022 -- Correction to results subsection
- EULAR revised recommendations for the management of fibromyalgia, Annals of the Rheumatic Diseases, 2024 -- Guidance on fibromyalgia management
- Erratum: 3D Reconstruction from Microscopic Imaging for Computer-Assisted Eye Surgery
- Erratum: Outcomes of Isokinetic and Functional Shoulder Assessment Following Arthroscopic Capsulolabral Stabilization
- Journal of Neuro-Oncology — Amendment to: Pediatric Central Nervous System Tumors in Patients Aged Under 5: Insights on Treatment Challenges, Survival Rates, and Long-Term Outcomes
- Erratum: Comparing the "true" acetabular anteversion angle (AV angle) using 2D CT and 3D modeling techniques
- EULAR revised recommendations for the management of fibromyalgia
- https://academic.oup.com/painmedicine/article/27/3/350/8280526
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
